Vasopressor drugs for pulmonary hypertension crisis
Treatments studied
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial tests if vasopressor medicines (dopamine, norepinephrine, epinephrine) can help people having a pulmonary hypertensive crisis (a sudden worsening of high blood pressure in the lungs). It aims to find out if these drugs are safe and effective when given by IV in the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You must have a confirmed diagnosis of pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)
- You must be currently experiencing a pulmonary hypertensive crisis (sudden severe symptoms)
- You must be receiving both diagnosis and treatment while staying in the hospital
- You must not have already received any of the study drugs (dopamine, norepinephrine, or epinephrine) through an IV before starting the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with different types of high blood pressure in the lungs (pulmonary hypertension) to see how starting specific lung blood vessel medicines affects outcomes. It may help improve how clinicians choose and monitor treatment over time.
This trial tests whether vasopressin (a medication that tightens blood vessels) works better than norepinephrine for managing blood pressure after pulmonary endarterectomy surgery, which removes blood clots from the lungs. The goal is to find the safest, most effective blood-pressure support during recovery.
This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.
This trial compares two medicines (dopamine and norepinephrine) to see which works better for raising blood pressure in newborns who have both low blood pressure and high blood pressure in the lungs. Both medicines are given through a vein to help stabilize your baby's blood pressure.
This trial uses a special belt (EIT) to see how two different blood pressure medicines affect the balance of air and blood flow in the lungs of people on breathing machines in the ICU.
This trial tests the right amount of a blood pressure medicine (vasopressor) for newborns and infants under 2 years old during surgery. It aims to find a safe and effective dose to support their blood pressure during anesthesia.
Hear when a new Pulmonary Arterial Hypertension (PAH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.